HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan
— Launch follows approval by Japanese Ministry of Health, Labour and Welfare in September 2024 — — Milestone payment to be made to […]
Lead Real Estate Co., LTD. Reports Higher Revenues and Net Income, on the Strength of Rising Real Estate Sales, for the Fiscal Year ended on June 30, 2024
TOKYO, Nov. 21, 2024 (GLOBE NEWSWIRE) — Lead Real Estate Co., LTD. (Nasdaq: LRE), (“LRE” or the “Company”), a Japanese […]
Abacus Life Announces Pricing of Public Offering of Common Stock
ORLANDO, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative […]
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
MELBOURNE, Australia, Nov. 21, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief […]
Beneficient Reports to Kansas Legislative Committee on Its Positive Developments and the Digital Transformation of the Alternative Asset Industry
DALLAS, Nov. 21, 2024 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), whose subsidiary Beneficient Fiduciary Financial, L.L.C., […]
Inspirato Partners with BLADE Urban Air Mobility to Enhance Member Travel Experiences
DENVER, Nov. 21, 2024 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato” or the “Company”) (NASDAQ: ISPO), the premier members-only luxury vacation […]
Bleichroeder Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing December 2, 2024
New York, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) — Bleichroeder Acquisition Corp. I (Nasdaq: BACQU) (the “Company”) announced today that, […]
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
MIPLYFFA, the first FDA-approved treatment for Niemann-Pick disease type C, is available at Zevra’s specialty pharmacy for dispense AmplifyAssist™, Zevra’s […]
BioXcel Therapeutics Announces Proposed Public Offering
NEW HAVEN, Conn., Nov. 21, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing […]
Expand Energy Corporation Announces Pricing of Senior Notes Offering
OKLAHOMA CITY, Nov. 21, 2024 (GLOBE NEWSWIRE) — Expand Energy Corporation (NASDAQ: EXE) (“Expand Energy”) announced today the pricing of […]
